NIAB scientists working on next generation vaccine against ‘Leptospirosis’
NIAB scientists working on next generation vaccine against ‘Leptospirosis’
One million cases of human leptospirosis are reported every year resulting in an estimated 60,000 deaths, while vaccination is a cost-effective and secure preventive measure to combat this disease, the current killed vaccine only provides short-term immunity specific to certain strains of the zoonotic disease, say scientists
One million cases of human leptospirosis are reported every year resulting in an estimated 60,000 deaths, while vaccination is a cost-effective and secure preventive measure to combat this disease, the current killed vaccine only provides short-term immunity specific to certain strains of the zoonotic disease, say scientists